EUVIMEDEUVIMED entdecken
Crossref

The effect of cardiovascular drugs on erectile function: Literature review

K. P. Raevskiy, O. Yu. Nesterova, A. A. Kamalov, Ya. A. Orlova

Meditsinskiy sovet = Medical Council · 26.06.2026 · (7) · 238-246

DOI: 10.21518/ms2026-018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Meditsinskiy sovet = Medical Council, online erschienen am 26.06.2026. Verfasst von K. P. Raevskiy und 3 weiteren Autor:innen. Die Arbeit nennt 88 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Erectile dysfunction (ED) is a common problem among the male population over 40 years old. Arterial hypertension, dyslipidemia and other cardiovascular diseases (CVDs), as well as some of the medications which are used to treat CVDs can affect erectile function (EF). This article discusses current data about cardiovascular drugs effect on EF and analyzes scientific literature from the following scientific databases: PubMed, ScienceDirect, and eLIBRARY.RU. Angiotensin II receptor blockers have a positive effect on EF. ED, as one of the possible side effects, can be observed during treatment by most beta-blockers (with the exception of nebivolol), diuretics, and non-selective mineralocorticoid receptor antagonists. There is no convincing evidence of a negative effect of angiotensin-converting enzyme inhibitors, calcium channel blockers, selective mineralocorticoid receptor antagonists, and metoprolol on EF. The data of the effect of statin therapy on EF is contradictory. There is a limited number of studies about interaction between angiotensin receptors, neprilysin inhibitors and EF. In many studies subjective methods of EF assessment are used. CVDs and ED have common risk factors and pathogenic mechanisms. Large-scale biobank studies using Mendelian randomization show that ED is more strongly associated with the presence of CVDs rather than with the medications. To clarify CVD drugs effects on EF it is necessary to conduct studies with objective assessment of EF using nighttime penile tumescence monitoring. Knowledge of the characteristics of CVD drugs allows doctors to provide patient with an individualized therapy without adverse events, and ensures a high level of patient adherence to treatment.

Zitieren

APA

Raevskiy, K. P., Nesterova, O. Y., Kamalov, A. A., & Orlova, Y. A. (2026). The effect of cardiovascular drugs on erectile function: Literature review. Meditsinskiy sovet = Medical Council, 238-246. https://doi.org/10.21518/ms2026-018

Vancouver

Raevskiy KP, Nesterova OY, Kamalov AA, Orlova YA. The effect of cardiovascular drugs on erectile function: Literature review. Meditsinskiy sovet = Medical Council. 2026:238-246. doi:10.21518/ms2026-018

BibTeX
@article{Raevskiy2026,
  author = {Raevskiy, K. P. and Nesterova, O. Yu. and Kamalov, A. A. and Orlova, Ya. A.},
  title = {The effect of cardiovascular drugs on erectile function: Literature review},
  journal = {Meditsinskiy sovet = Medical Council},
  year = {2026},
  number = {7},
  pages = {238--246},
  doi = {10.21518/ms2026-018}
}
Kostenlos starten →